{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:50:29Z","timestamp":1781106629981,"version":"3.54.1"},"reference-count":22,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Widespread and equitable access to testing remains critical to controlling the COVID-19 pandemic, which has disproportionately affected medically underserved communities.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether secondary distribution of COVID-19 self-test (ST) kits, in which an individual distributes ST kits to contacts in their social networks, increases COVID-19 testing.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>The COVID-19 Self-Testing Through Rapid Network Distribution study was a randomized clinical trial conducted between May 2021 and September 2023 at 4 federally qualified health centers serving medically underserved populations in Philadelphia, Pennsylvania. Participants were adults aged 18 years or older presenting to federally qualified health centers without SARS-CoV-2 infection in the past 90 days. Participants were randomized 1:1 to receive 5 COVID-19 ST kits or 5 clinic test referral cards to distribute to contacts in their social network, and testing among their social network contacts was measured. Investigators were masked to study group assignment. Data were analyzed from December 11, 2023, to August 23, 2024.<\/jats:p><\/jats:sec>Intervention<\/jats:title>Participants in the intervention group received 5 COVID-19 ST kits; control participants received 5 clinic test referral cards.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was confirmed testing among at least 2 network contacts 8 weeks after randomization. Secondary outcomes included the proportion of participants with at least 1 network contact tested and total number of network contacts reached.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 776 participants (median [IQR] age, 44 [32-57] years; 428 [55.2%] cisgender female) were included in the study, of whom 388 participants were randomized to the ST intervention group and 388 participants were randomized to the control group. There were 112 Hispanic or Latine participants (14.4%), 459 non-Hispanic Black participants (59.1%), and 120 non-Hispanic White participants (15.5%). There was no difference between study groups in the primary outcome, with 5 participants (1.3%) in the ST group vs 2 participants (0.5%) in the control group having at least 2 contacts confirmed tested at the 8-week follow-up (risk difference, 0.0077; 95% CI \u22120.0056 to 0.0210; P<\/jats:italic>\u2009=\u2009.45).<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>This randomized clinical trial found that secondary distribution of COVID-19 ST kits had no effect on confirmed testing rates among network contacts, which were low in both study groups. Despite these null findings, the study provides insight that may be useful when designing and implementing ST trials.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT04797858<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.13708","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:00:31Z","timestamp":1749049231000},"page":"e2513708","source":"Crossref","is-referenced-by-count":1,"title":["Provision of COVID-19 Self-Test Kits to Patients for Distribution to Social Contacts"],"prefix":"10.1001","volume":"8","author":[{"given":"Cedric H.","family":"Bien-Gund","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa J.","family":"Stephens-Shields","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, Epidemiology, and Informatics, University of Pennsylvania Perelman School of Medicine, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trisha","family":"Acri","sequence":"additional","affiliation":[{"name":"Courage Medicine Health Center, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Dugosh","sequence":"additional","affiliation":[{"name":"Public Health Management Corporation, Philadelphia, Pennsylvania"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gross","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia"},{"name":"Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,6,4]]},"reference":[{"issue":"1631","key":"zoi250453r1","doi-asserted-by":"publisher","first-page":"n1631","DOI":"10.1136\/bmj.n1631","article-title":"COVID-19, equity, and inclusiveness.","volume":"373","author":"Evans","year":"2021","journal-title":"BMJ"},{"issue":"2","key":"zoi250453r2","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.37067","article-title":"Disparities in SARS-CoV-2 testing in Massachusetts during the COVID-19 pandemic.","volume":"4","author":"Dryden-Peterson","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"1","key":"zoi250453r3","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1186\/s12889-022-14450-9","article-title":"Geographic disparities in COVID-19 testing and outcomes in Florida.","volume":"23","author":"Khan","year":"2023","journal-title":"BMC Public Health"},{"issue":"3","key":"zoi250453r4","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amepre.2020.06.005","article-title":"Disparities in COVID-19 testing and positivity in New York City.","volume":"59","author":"Lieberman-Cribbin","year":"2020","journal-title":"Am J Prev Med"},{"issue":"9","key":"zoi250453r5","doi-asserted-by":"publisher","first-page":"e2921","DOI":"10.1093\/cid\/ciaa1848","article-title":"Understanding drivers of coronavirus disease 2019 (COVID-19) Racial disparities: a population-level analysis of COVID-19 testing among Black and White populations.","volume":"73","author":"Mody","year":"2021","journal-title":"Clin Infect Dis"},{"key":"zoi250453r6","doi-asserted-by":"publisher","DOI":"10.1016\/j.ypmed.2021.106463","article-title":"Disparities in the distribution of COVID-19 testing sites in Black and Latino areas in New York City.","volume":"147","author":"Grigsby-Toussaint","year":"2021","journal-title":"Prev Med"},{"issue":"7","key":"zoi250453r7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD013705.pub3","article-title":"Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.","volume":"7","author":"Dinnes","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"zoi250453r9","doi-asserted-by":"publisher","DOI":"10.1016\/j.pmedr.2023.102567","article-title":"Disparities in access to COVID-19 testing in Los Angeles County.","volume":"37","author":"Khalifeh","year":"2023","journal-title":"Prev Med Rep"},{"key":"zoi250453r10","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2024.1337745","article-title":"Salient beliefs related to secondary distribution of COVID-19 self-test kits within social networks.","volume":"12","author":"Bien-Gund","year":"2024","journal-title":"Front Public Health"},{"issue":"6","key":"zoi250453r11","doi-asserted-by":"publisher","first-page":"e266","DOI":"10.1016\/S2352-3018(16)00041-2","article-title":"Promoting male partner HIV testing and safer sexual decision making through secondary distribution of self-tests by HIV-negative female sex workers and women receiving antenatal and post-partum care in Kenya: a cohort study.","volume":"3","author":"Thirumurthy","year":"2016","journal-title":"Lancet HIV"},{"issue":"10","key":"zoi250453r12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1003365","article-title":"Impact of providing free HIV self-testing kits on frequency of testing among men who have sex with men and their sexual partners in China: a randomized controlled trial.","volume":"17","author":"Zhang","year":"2020","journal-title":"PLoS Med"},{"issue":"11","key":"zoi250453r13","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1002166","article-title":"Promoting partner testing and couples testing through secondary distribution of HIV self-tests: a randomized clinical trial.","volume":"13","author":"Masters","year":"2016","journal-title":"PLoS Med"},{"issue":"4","key":"zoi250453r14","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1097\/PHH.0000000000001688","article-title":"Experiences of health departments on community engagement and implementation of a COVID-19 self-testing program.","volume":"29","author":"Lane-Barlow","year":"2023","journal-title":"J Public Health Manag Pract"},{"issue":"1","key":"zoi250453r15","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1089\/heq.2022.0185","article-title":"The importance of community-based and community-partnered COVID-19 testing for reducing disparities among African American populations.","volume":"8","author":"Hamilton-Burgess","year":"2024","journal-title":"Health Equity"},{"key":"zoi250453r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.cct.2021.106585","article-title":"The COVID-19 Self-Testing through Rapid Network Distribution (C-STRAND) trial: a randomized controlled trial to increase COVID-19 testing in underserved populations.","volume":"110","author":"Bien-Gund","year":"2021","journal-title":"Contemp Clin Trials"},{"issue":"10","key":"zoi250453r17","doi-asserted-by":"publisher","first-page":"2366","DOI":"10.1039\/D3LC00118K","article-title":"Pivot, persevere, or perish: how Ellume Health overcame development and regulatory obstacles to become the first authorized over-the-counter COVID-19 test in the United States.","volume":"23","author":"Greenleaf","year":"2023","journal-title":"Lab Chip"},{"issue":"1","key":"zoi250453r18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1353\/cpr.2024.a922324","article-title":"Lessons from two Latino communities working with academic partners to increase access to COVID-19 testing.","volume":"18","author":"Garibay","year":"2024","journal-title":"Prog Community Health Partnersh"},{"issue":"5","key":"zoi250453r19","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1089\/pop.2023.0016","article-title":"New York City\u2019s community-based organizations and the COVID-19 pandemic: a descriptive analysis of local organizations\u2019 response efforts and their role during public health crises.","volume":"26","author":"Madden","year":"2023","journal-title":"Popul Health Manag"},{"issue":"5","key":"zoi250453r20","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/QAI.0000000000001709","article-title":"HIV self-testing increases HIV testing frequency in high-risk men who have sex with men: a randomized controlled trial.","volume":"78","author":"Katz","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"issue":"12","key":"zoi250453r21","doi-asserted-by":"publisher","first-page":"e736","DOI":"10.1016\/S2352-3018(21)00248-4","article-title":"The effect of providing women sustained access to HIV self-tests on male partner testing, couples testing, and HIV incidence in Kenya: a cluster-randomised trial.","volume":"8","author":"Thirumurthy","year":"2021","journal-title":"Lancet HIV"},{"issue":"6","key":"zoi250453r22","doi-asserted-by":"publisher","DOI":"10.1002\/jia2.25937","article-title":"HIV testing and linkage to ART following secondary distribution of HIV self-test kits to male partners of women living with HIV: a pilot randomized control trial in Mpumalanga, South Africa.","volume":"25","author":"Joseph Davey","year":"2022","journal-title":"J Int AIDS Soc"},{"key":"zoi250453r8","unstructured":"The White House. Fact sheet: the Biden Administration to begin distributing at-home, rapid COVID-19 tests to Americans for free 2022. Accessed June 13, 2024. https:\/\/www.presidency.ucsb.edu\/documents\/fact-sheet-the-biden-administration-announces-americans-can-additional-free-home-rapid"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2834881\/biengund_2025_oi_250453_1748437534.47185.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:00:32Z","timestamp":1749049232000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2834881"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,6,4]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6,2]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.13708","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,4]]}}}